Adjuvant chemotherapy for high-risk low-stage germ-cell tumours

Curr Opin Urol. 2002 Sep;12(5):431-4. doi: 10.1097/00042307-200209000-00011.

Abstract

Purpose of review: To review the assessment and management of early germ-cell tumours.

Recent findings: A role has evolved for adjuvant chemotherapy in stage I disease postorchidectomy and in the primary management of stage II disease.

Summary: A range of approaches offer high survival in early germ-cell tumours. Treatment should factor in patient choice and resource issues. More sensitive imaging with Positron Emission Tomography may allow more appropriate treatment decisions.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Chemotherapy, Adjuvant
  • Germinoma / drug therapy*
  • Germinoma / pathology*
  • Germinoma / surgery
  • Humans
  • Male
  • Neoplasm Staging
  • Orchiectomy
  • Risk Assessment
  • Testicular Neoplasms / drug therapy*
  • Testicular Neoplasms / pathology*
  • Testicular Neoplasms / surgery